603.8K XNYS Volume
XNYS 19 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Mary Ann E. Moore | EVP, GC, Chief Admin Off & Sec | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Mar 2025 | 26,497 | 100,338 (0%) | 0% | 0 | Common Stock | |
| Mary Ann E. Moore | EVP, GC, Chief Admin Off & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.77 per share. | 01 Mar 2025 | 8,975 | 126,835 (0%) | 0% | 14.8 | 132,561 | Common Stock |
| Kasandra H. Rossi | EVP, CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.77 per share. | 01 Mar 2025 | 3,718 | 51,151 (0%) | 0% | 14.8 | 54,915 | Common Stock |
| Shirley A. Weis | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Feb 2025 | 17,668 | 18,360 (0%) | 0% | 0 | Common Stock | |
| Mark S. Ordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2025 | 640,000 | 640,000 | - | - | Performance Share Unit | |
| H. Kasandra Rossi | EVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2024 | 11,112 | 54,869 (0%) | 0% | 0 | Common Stock | |
| Mark S. Ordan | Director | Sale of securities on an exchange or to another person at price $ 15.35 per share. | 13 Nov 2024 | 27,600 | 138,683 (0%) | 0% | 15.4 | 423,660 | Common Stock |
| Mary Ann E. Moore | EVP, GC, Chief Admin Off & Sec | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 08 Nov 2024 | 8,108 | 135,810 (0%) | 0% | 16 | 129,728 | Common Stock |
| James D. Swift | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.79 per share. | 30 Aug 2024 | 11,100 | 170,001 (0%) | 0% | 10.8 | 119,769 | Common Stock |
| C. Marc Richards | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.08 per share. | 09 Aug 2024 | 17,438 | 175,347 (0%) | 0% | 10.1 | 175,775 | Common Stock |
| C. Marc Richards | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.08 per share. | 09 Aug 2024 | 32,562 | 192,785 (0%) | 0% | 10.1 | 328,225 | Common Stock |
| C. Marc Richards | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 95,760 | 225,347 (0%) | 0% | 0 | Common Stock | |
| Mary Ann E. Moore | EVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 68,400 | 143,918 (0%) | 0% | 0 | Common Stock | |
| James D. Swift | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 105,165 | 181,101 (0%) | 0% | 0 | Common Stock | |
| Lee A. Wood | EVP, Natl & Market Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.31 per share. | 01 Jun 2024 | 813 | 117,281 (0%) | 0% | 7.3 | 5,943 | Common Stock |
| Lee A. Wood | EVP, Natl & Market Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 51,300 | 118,094 (0%) | 0% | 0 | Common Stock | |
| Curtis B. Pickert | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 68,400 | 121,401 (0%) | 0% | 0 | Common Stock | |
| Curtis B. Pickert | EVP, Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jun 2024 | 2,332 | 118,318 (0%) | 0% | 0 | Common Stock | |
| Curtis B. Pickert | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.31 per share. | 01 Jun 2024 | 751 | 120,650 (0%) | 0% | 7.3 | 5,490 | Common Stock |
| Guy P. Sansone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 18,360 | 68,321 (0%) | 0% | 0 | Common Stock | |
| Mark S. Ordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 18,360 | 166,283 (0%) | 0% | 0 | Common Stock | |
| John M. Starcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 18,360 | 54,637 (0%) | 0% | 0 | Common Stock | |
| Michael A. Rucker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 18,360 | 58,152 (0%) | 0% | 0 | Common Stock | |
| Shirley A. Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 18,360 | 36,028 (0%) | 0% | 0 | Common Stock | |
| Thomas A. McEachin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 18,360 | 54,646 (0%) | 0% | 0 | Common Stock | |
| Sylvia Jean Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 18,360 | 29,191 (0%) | 0% | 0 | Common Stock | |
| Curtis B. Pickert | EVP, Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Mar 2024 | 12,923 | 53,001 (0%) | 0% | 0 | Common Stock | |
| C. Marc Richards | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.15 per share. | 01 Mar 2024 | 21,428 | 129,587 (0%) | 0% | 9.1 | 196,066 | Common Stock |
| Mary Ann E. Moore | EVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.15 per share. | 01 Mar 2024 | 5,867 | 75,518 (0%) | 0% | 9.1 | 53,683 | Common Stock |
| James D. Swift | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.15 per share. | 01 Mar 2024 | 14,938 | 75,936 (0%) | 0% | 9.2 | 136,683 | Common Stock |
| Lee Wood | EVP, Natl & Market Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.15 per share. | 01 Mar 2024 | 4,962 | 66,794 (0%) | 0% | 9.1 | 45,402 | Common Stock |
| Curtis B. Pickert | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.15 per share. | 01 Mar 2024 | 9,160 | 65,924 (0%) | 0% | 9.2 | 83,814 | Common Stock |
| E. Moore Mary Ann | EVP, General Counsel & Sec | Sale of securities on an exchange or to another person at price $ 9.62 per share. | 14 Dec 2023 | 970 | 81,385 (0%) | 0% | 9.6 | 9,331 | Common Stock |
| James D. Swift | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 9.58 per share. | 14 Dec 2023 | 5,764 | 90,874 (0%) | 0% | 9.6 | 55,219 | Common Stock |
| E. Moore Mary Ann | EVP, General Counsel & Sec | Sale of securities on an exchange or to another person at price $ 9.62 per share. | 14 Dec 2023 | 1,150 | 15,730 (0%) | 0% | 9.6 | 11,063 | Common Stock |
| James D. Swift | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.14 per share. | 14 Jun 2023 | 13,193 | 96,638 (0%) | 0% | 14.1 | 186,549 | Common Stock |
| Curtis B. Pickert | EVP, Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2023 | 1,166 | 75,084 (0%) | 0% | 0 | Common Stock | |
| Lee Wood | EVP, Natl & Market Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.30 per share. | 01 Jun 2023 | 407 | 71,756 (0%) | 0% | 13.3 | 5,413 | Common Stock |
| Curtis B. Pickert | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.30 per share. | 01 Jun 2023 | 376 | 76,250 (0%) | 0% | 13.3 | 5,001 | Common Stock |
| Mark S. Ordan | Director | Sale of securities on an exchange or to another person at price $ 13.26 per share. | 25 May 2023 | 33,000 | 147,923 (0%) | 0% | 13.3 | 437,580 | Common Stock |
| Shirley A. Weis | Director | Sale of securities on an exchange or to another person at price $ 13.55 per share. | 18 May 2023 | 17,993 | 18,675 (0%) | 0% | 13.5 | 243,805 | Common Stock |
| Shirley A. Weis | Director | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 18 May 2023 | 1,007 | 17,668 (0%) | 0% | 13.6 | 13,725 | Common Stock |
| Curtis B. Pickert | EVP, Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 May 2023 | 5,984 | 76,626 (0%) | 0% | 0 | Common Stock | |
| Sylvia Jean Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 10,831 | 10,831 (0%) | 0% | 0 | Common Stock | |
| Guy P. Sansone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 10,965 | 49,961 (0%) | 0% | 0 | Common Stock | |
| Mark S. Ordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 9,463 | 180,923 (0%) | 0% | 0 | Common Stock | |
| John M. Starcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 10,965 | 36,277 (0%) | 0% | 0 | Common Stock | |
| Michael A. Rucker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 10,965 | 39,792 (0%) | 0% | 0 | Common Stock | |
| Shirley A. Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 10,965 | 36,668 (0%) | 0% | 0 | Common Stock | |
| Thomas A. McEachin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 10,965 | 36,286 (0%) | 0% | 0 | Common Stock | |
| C. Marc Richards | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 45,308 | 161,006 (0%) | 0% | 0 | Common Stock | |
| C. Marc Richards | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.74 per share. | 01 Mar 2023 | 9,991 | 151,015 (0%) | 0% | 15.7 | 157,258 | Common Stock |
| Mary Ann E. Moore | EVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.74 per share. | 01 Mar 2023 | 2,345 | 82,355 (0%) | 0% | 15.7 | 36,910 | Common Stock |
| Mary Ann E. Moore | EVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 55,664 | 84,700 (0%) | 0% | 0 | Common Stock | |
| James D. Swift | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.74 per share. | 01 Mar 2023 | 9,909 | 109,831 (0%) | 0% | 15.7 | 155,968 | Common Stock |
| James D. Swift | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 49,758 | 119,740 (0%) | 0% | 0 | Common Stock | |
| Lee Wood | EVP, Natl & Market Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.74 per share. | 01 Mar 2023 | 2,044 | 72,163 (0%) | 0% | 15.7 | 32,173 | Common Stock |
| Lee Wood | EVP, Natl & Market Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 39,806 | 74,207 (0%) | 0% | 0 | Common Stock | |
| Curtis B. Pickert | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 55,664 | 84,910 (0%) | 0% | 0 | Common Stock | |
| Curtis B. Pickert | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.74 per share. | 01 Mar 2023 | 2,300 | 82,610 (0%) | 0% | 15.7 | 36,202 | Common Stock |
| Mark S. Ordan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.86 per share. | 31 Dec 2022 | 98,932 | 247,713 (0%) | 0% | 14.9 | 1,470,130 | Common Stock |
| Mark S. Ordan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.45 per share. | 21 Nov 2022 | 22,166 | 346,645 (0%) | 0% | 15.5 | 342,465 | Common Stock |
| James D. Swift | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.31 per share. | 07 Nov 2022 | 24,000 | 87,956 (0%) | 0% | 15.3 | 367,440 | Common Stock |
| Dominic J. Andreano | EVP, General Counsel and Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.81 per share. | 26 Sep 2022 | 4,267 | 189,440 (0%) | 0% | 16.8 | 71,728 | Common Stock |
| Guy P. Sansone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 8,480 | 38,996 (0%) | 0% | 0 | Common Stock | |
| Roger J. Medel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 8,480 | 747,930 (0%) | 0% | 0 | Common Stock | |
| John M. Starcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 8,480 | 25,312 (0%) | 0% | 0 | Common Stock | |
| Michael A. Rucker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 8,480 | 28,827 (0%) | 0% | 0 | Common Stock | |
| Shirley A. Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 8,480 | 25,703 (0%) | 0% | 0 | Common Stock | |
| Thomas A. McEachin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 8,480 | 25,321 (0%) | 0% | 0 | Common Stock | |
| Mark S. Ordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 76,253 | 313,249 (0%) | 0% | 0 | Common Stock | |
| Mark S. Ordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 76,253 | 389,502 (0%) | 0% | 0 | Common Stock | |
| Mark S. Ordan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.47 per share. | 01 Mar 2022 | 20,691 | 368,811 (0%) | 0% | 23.5 | 485,618 | Common Stock |
| C. Marc Richards | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 30,502 | 122,572 (0%) | 0% | 0 | Common Stock | |
| C. Marc Richards | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 30,501 | 153,073 (0%) | 0% | 0 | Common Stock | |
| C. Marc Richards | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.47 per share. | 01 Mar 2022 | 6,874 | 146,199 (0%) | 0% | 23.5 | 161,333 | Common Stock |
| Dominic J. Andreano | EVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 29,412 | 170,930 (0%) | 0% | 0 | Common Stock | |
| Dominic J. Andreano | EVP, General Counsel and Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.47 per share. | 01 Mar 2022 | 6,635 | 193,707 (0%) | 0% | 23.5 | 155,723 | Common Stock |
| Dominic J. Andreano | EVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 29,412 | 200,342 (0%) | 0% | 0 | Common Stock | |
| Roger Mack Hinson | Pres., PDX & OBX Medical Group | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.47 per share. | 01 Mar 2022 | 10,244 | 109,457 (0%) | 0% | 23.5 | 240,427 | Common Stock |
| Mary Ann E. Moore | EVP Chief ERM/Legal Ops Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 16,340 | 30,561 (0%) | 0% | 0 | Common Stock | |
| Mary Ann E. Moore | EVP Chief ERM/Legal Ops Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.47 per share. | 01 Mar 2022 | 1,525 | 45,376 (0%) | 0% | 23.5 | 35,792 | Common Stock |
| Mary Ann E. Moore | EVP Chief ERM/Legal Ops Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 16,340 | 46,901 (0%) | 0% | 0 | Common Stock | |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 26.44 per share. | 10 Jan 2022 | 59,893 | 779,557 (0%) | 0% | 26.4 | 1,583,571 | Common Stock |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 26.58 per share. | 10 Jan 2022 | 40,107 | 739,450 (0%) | 0% | 26.6 | 1,066,044 | Common Stock |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 27.42 per share. | 05 Jan 2022 | 12,639 | 839,450 (0%) | 0% | 27.4 | 346,561 | Common Stock |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 27.19 per share. | 30 Dec 2021 | 45,397 | 946,014 (1%) | 0% | 27.2 | 1,234,344 | Common Stock |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 27.28 per share. | 27 Dec 2021 | 25,000 | 991,411 (1%) | 0% | 27.3 | 682,000 | Common Stock |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 27.28 per share. | 27 Dec 2021 | 44,514 | 1,016,411 (1%) | 0% | 27.3 | 1,214,342 | Common Stock |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 27.17 per share. | 27 Dec 2021 | 66,868 | 1,060,925 (1%) | 0% | 27.2 | 1,816,804 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 28.45 per share. | 10 Nov 2021 | 5,000 | 96,666 (0%) | 0% | 28.5 | 142,250 | Common Stock |
| Roger Mack Hinson | Pres., PDX & OBX Medical Group | Sale of securities on an exchange or to another person at price $ 28.38 per share. | 10 Nov 2021 | 8,800 | 107,391 (0%) | 0% | 28.4 | 249,744 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 26.87 per share. | 29 Oct 2021 | 9,238 | 101,666 (0%) | 0% | 26.9 | 248,225 | Common Stock |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 28 Oct 2021 | 10,387 | 1,127,793 (1%) | 0% | 29 | 301,223 | Common Stock |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 04 Oct 2021 | 1,270 | 1,138,180 (1%) | 0% | 29 | 36,830 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 31.83 per share. | 02 Sep 2021 | 10,000 | 110,843 (0%) | 0% | 31.8 | 318,300 | Common Stock |
| Mark S. Ordan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.65 per share. | 30 Aug 2021 | 95,000 | 303,425 (0%) | 0% | 17.7 | 1,676,750 | Common Stock |
| Mark S. Ordan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2021 | 95,000 | 455,331 | - | - | Employee Stock Option (right to buy) | |
| Mark S. Ordan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 35.09 per share. | 30 Aug 2021 | 95,000 | 208,425 (0%) | 0% | 35.1 | 3,333,550 | Common Stock |
| Roger Mack Hinson | Pres., PDX & OBX Medical Group | Sale of securities on an exchange or to another person at price $ 32.35 per share. | 10 Aug 2021 | 8,799 | 116,129 (0%) | 0% | 32.4 | 284,648 | Common Stock |
| Roger J. Medel | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.77 per share. | 12 Jul 2021 | 83,092 | 1,139,450 (1%) | 0% | 29.8 | 2,473,649 | Common Stock |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 30.31 per share. | 01 Jul 2021 | 100,000 | 1,222,542 (1%) | 0% | 30.3 | 3,031,000 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.98 per share. | 01 Jun 2021 | 7,858 | 120,785 (0%) | 0% | 32.0 | 251,299 | Common Stock |
| Guy P. Sansone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 4,885 | 30,516 (0%) | 0% | 0 | Common Stock | |
| Paul G. Gabos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 4,885 | 29,198 (0%) | 0% | 0 | Common Stock | |
| Waldemar A. Carlo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 4,885 | 36,687 (0%) | 0% | 0 | Common Stock | |
| Roger J. Medel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 4,885 | 1,322,542 (1%) | 0% | 0 | Common Stock | |
| Manuel Kadre | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 4,885 | 129,198 (0%) | 0% | 0 | Common Stock | |
| John M. Starcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 4,885 | 16,832 (0%) | 0% | 0 | Common Stock | |
| Michael A. Rucker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 4,885 | 20,347 (0%) | 0% | 0 | Common Stock | |
| Shirley A. Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 4,885 | 17,223 (0%) | 0% | 0 | Common Stock | |
| Karey D. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 4,885 | 22,663 (0%) | 0% | 0 | Common Stock | |
| Thomas A. McEachin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 4,885 | 16,841 (0%) | 0% | 0 | Common Stock | |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 25.81 per share. | 01 Apr 2021 | 782 | 1,317,657 (1%) | 0% | 25.8 | 20,183 | Common Stock |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 25.40 per share. | 01 Apr 2021 | 99,218 | 1,318,439 (1%) | 0% | 25.4 | 2,520,137 | Common Stock |
| Mark S. Ordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 71,429 | 136,996 (0%) | 0% | 0 | Common Stock | |
| Mark S. Ordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 71,429 | 208,425 (0%) | 0% | 0 | Common Stock | |
| Roger J. Medel | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.43 per share. | 01 Mar 2021 | 72,575 | 1,417,657 (1%) | 0% | 24.4 | 1,773,007 | Common Stock |
| C. Marc Richards | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 28,571 | 52,069 (0%) | 0% | 0 | Common Stock | |
| C. Marc Richards | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 28,572 | 80,641 (0%) | 0% | 0 | Common Stock | |
| Dominic J. Andreano | EVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 27,551 | 102,945 (0%) | 0% | 0 | Common Stock | |
| Dominic J. Andreano | EVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 27,552 | 130,497 (0%) | 0% | 0 | Common Stock | |
| John C. Pepia | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 10,205 | 130,858 (0%) | 0% | 0 | Common Stock | |
| John C. Pepia | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 10,204 | 120,653 (0%) | 0% | 0 | Common Stock | |
| John C. Pepia | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.43 per share. | 01 Mar 2021 | 2,568 | 128,573 (0%) | 0% | 24.4 | 62,736 | Common Stock |
| Roger Mack Hinson | Pres., PDX & OBX Medical Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 30,612 | 100,249 (0%) | 0% | 0 | Common Stock | |
| Roger Mack Hinson | Pres., PDX & OBX Medical Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 30,613 | 130,862 (0%) | 0% | 0 | Common Stock | |
| Roger Mack Hinson | Pres., PDX & OBX Medical Group | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.43 per share. | 01 Mar 2021 | 6,244 | 124,800 (0%) | 0% | 24.4 | 152,541 | Common Stock |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 23.41 per share. | 04 Jan 2021 | 47,039 | 1,543,193 (1%) | 0% | 23.4 | 1,101,183 | Common Stock |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 23.89 per share. | 04 Jan 2021 | 52,961 | 1,490,232 (1%) | 0% | 23.9 | 1,265,238 | Common Stock |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 23.04 per share. | 09 Dec 2020 | 33,194 | 1,590,232 (1%) | 0% | 23.0 | 764,919 | Common Stock |
| Roger J. Medel | Director | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 09 Dec 2020 | 66,806 | 1,623,426 (1%) | 0% | 23.0 | 1,536,672 | Common Stock |
| Roger J. Medel | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Dec 2020 | 1,645 | 1,690,232 (2%) | 0% | 0 | Common Stock | |
| Roger J. Medel | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Dec 2020 | 12,735 | 1,691,877 (2%) | 0% | 0 | Common Stock | |
| Dominic J. Andreano | EVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2020 | 21,686 | 75,394 (0%) | 0% | 0 | Common Stock | |
| Dominic J. Andreano | EVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2020 | 96,000 | 96,000 | - | - | Employee Stock Option (right to buy) | |
| Dominic J. Andreano | EVP, General Counsel and Secy | Sale of securities on an exchange or to another person at price $ 18.93 per share. | 15 Sep 2020 | 22,000 | 53,708 (0%) | 0% | 18.9 | 416,425 | Common Stock |
| Stephen D. Farber | Former Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Jul 2020 | 200,000 | 78,027 (0%) | 0% | 0 | Common Stock | |
| Guy P. Sansone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2020 | 11,331 | 25,631 (0%) | 0% | 0 | Common Stock | |
| Mark S. Ordan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.65 per share. | 12 Jul 2020 | 47,747 | 65,567 (0%) | 0% | 17.7 | 842,735 | Common Stock |
| Mark S. Ordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2020 | 113,314 | 113,314 (0%) | 0% | 0 | Common Stock | |
| Mark S. Ordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2020 | 550,331 | 550,331 | - | - | Employee Stock Option (right to buy) | |
| Stephen D. Farber | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.65 per share. | 12 Jul 2020 | 151,581 | 278,027 (0%) | 0% | 17.7 | 2,675,405 | Common Stock |
| Dominic J. Andreano | EVP, General Counsel and Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.65 per share. | 12 Jul 2020 | 32,413 | 75,708 (0%) | 0% | 17.6 | 572,089 | Common Stock |
| John M. Starcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2020 | 11,331 | 11,947 (0%) | 0% | 0 | Common Stock | |
| Shirley A. Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2020 | 11,331 | 12,338 (0%) | 0% | 0 | Common Stock | |
| Thomas A. McEachin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2020 | 11,331 | 11,956 (0%) | 0% | 0 | Common Stock | |
| Stephen D. Farber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2020 | 200,000 | 429,608 (0%) | 0% | 0 | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.53 per share. | 01 Jun 2020 | 14,499 | 1,704,612 (2%) | 0% | 15.5 | 225,169 | Common Stock |
| Dominic J. Andreano | EVP, General Counsel and Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.53 per share. | 01 Jun 2020 | 1,179 | 108,121 (0%) | 0% | 15.5 | 18,310 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.53 per share. | 01 Jun 2020 | 329 | 110,449 (0%) | 0% | 15.5 | 5,109 | Common Stock |
| Stephen D. Farber | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.09 per share. | 01 Mar 2020 | 9,134 | 229,608 (0%) | 0% | 17.1 | 156,100 | Common Stock |
| Roger J. Medel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.09 per share. | 01 Mar 2020 | 43,137 | 1,719,111 (2%) | 0% | 17.1 | 737,211 | Common Stock |
| Dominic J. Andreano | EVP, General Counsel and Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.09 per share. | 01 Mar 2020 | 9,838 | 109,300 (0%) | 0% | 17.1 | 168,131 | Common Stock |
| Dominic J. Andreano | EVP, General Counsel and Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2020 | 9,828 | 119,138 (0%) | 0% | - | Common Stock | |
| Dominic J. Andreano | EVP, General Counsel and Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2020 | 9,828 | 0 | - | - | Restricted Shares Units | |
| John C. Pepia | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.09 per share. | 01 Mar 2020 | 3,023 | 110,615 (0%) | 0% | 17.1 | 51,663 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2020 | 7,862 | 0 | - | - | Restricted Shares Units | |
| John C. Pepia | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2020 | 7,862 | 113,638 (0%) | 0% | - | Common Stock | |
| Carlos A. Migoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,717 | 12,062 (0%) | 0% | 0 | Common Stock | |
| Enrique J. Sosa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,717 | 37,350 (0%) | 0% | 0 | Common Stock | |
| Pascal J. Goldschmidt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,717 | 15,538 (0%) | 0% | 0 | Common Stock | |
| Paul G. Gabos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,717 | 24,313 (0%) | 0% | 0 | Common Stock | |
| Stephen D. Farber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 88,791 | 238,742 (0%) | 0% | 0 | Common Stock | |
| Waldemar A. Carlo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,717 | 31,802 (0%) | 0% | 0 | Common Stock | |
| Cesar L. Alvarez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,717 | 48,403 (0%) | 0% | 0 | Common Stock | |
| Michael B. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,717 | 355,005 (0%) | 0% | 0 | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 227,525 | 1,762,248 (2%) | 0% | 0 | Common Stock | |
| Manuel Kadre | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,717 | 124,313 (0%) | 0% | 0 | Common Stock | |
| Dominic J. Andreano | EVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 49,945 | 109,310 (0%) | 0% | 0 | Common Stock | |
| Michael A. Rucker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,717 | 15,462 (0%) | 0% | 0 | Common Stock | |
| Karey D. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 4,717 | 17,778 (0%) | 0% | 0 | Common Stock | |
| John C. Pepia | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 18,498 | 105,776 (0%) | 0% | 0 | Common Stock | |
| David A. Clark | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.12 per share. | 01 Dec 2019 | 10,625 | 123,032 (0%) | 0% | 26.1 | 277,525 | Common Stock |
| Dominic J. Andreano | SVP, General Counsel and Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.12 per share. | 01 Dec 2019 | 2,952 | 59,365 (0%) | 0% | 26.1 | 77,106 | Common Stock |
| Pascal J. Goldschmidt | None | Sale of securities on an exchange or to another person at price $ 22.88 per share. | 01 Nov 2019 | 5,000 | 10,821 (0%) | 0% | 22.9 | 114,403 | Common Stock |
| Pascal J. Goldschmidt | None | Sale of securities on an exchange or to another person at price $ 20.81 per share. | 03 Sep 2019 | 5,000 | 15,821 (0%) | 0% | 20.8 | 104,050 | Common Stock |
| Stephen D. Farber | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.08 per share. | 01 Sep 2019 | 19,675 | 149,951 (0%) | 0% | 21.1 | 414,749 | Common Stock |
| Michael B. Fernandez | None | Purchase of securities on an exchange or from another person at price $ 21.35 per share. | 12 Aug 2019 | 61,205 | 350,288 (0%) | 0% | 21.4 | 1,306,837 | Common Stock |
| Michael B. Fernandez | None | Purchase of securities on an exchange or from another person at price $ 21.35 per share. | 12 Aug 2019 | 61,204 | 250,000 (0%) | 0% | 21.4 | 1,306,816 | Common Stock |
| Michael B. Fernandez | None | Purchase of securities on an exchange or from another person at price $ 21.68 per share. | 08 Aug 2019 | 64,243 | 64,243 (0%) | 0% | 21.7 | 1,392,596 | Common Stock |
| Michael B. Fernandez | None | Purchase of securities on an exchange or from another person at price $ 21.52 per share. | 08 Aug 2019 | 124,553 | 188,796 (0%) | 0% | 21.5 | 2,680,879 | Common Stock |
| Michael B. Fernandez | None | Purchase of securities on an exchange or from another person at price $ 21.52 per share. | 08 Aug 2019 | 124,553 | 289,083 (0%) | 0% | 21.5 | 2,680,879 | Common Stock |
| Michael B. Fernandez | None | Purchase of securities on an exchange or from another person at price $ 21.68 per share. | 08 Aug 2019 | 64,242 | 164,530 (0%) | 0% | 21.7 | 1,392,574 | Common Stock |
| David A. Clark | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.66 per share. | 01 Jun 2019 | 3,307 | 133,657 (0%) | 0% | 24.7 | 81,551 | Common Stock |
| Joseph M. Calabro | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.66 per share. | 01 Jun 2019 | 14,729 | 414,679 (0%) | 0% | 24.7 | 363,217 | Common Stock |
| Roger J. Medel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.66 per share. | 01 Jun 2019 | 24,155 | 1,534,723 (1%) | 0% | 24.7 | 595,662 | Common Stock |
| Dominic J. Andreano | SVP, General Counsel and Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.66 per share. | 01 Jun 2019 | 2,144 | 62,317 (0%) | 0% | 24.7 | 52,871 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2019 | 50,690 | 86,758 (0%) | 0% | 0 | Common Stock | |
| Pascal J. Goldschmidt | None | Sale of securities on an exchange or to another person at price $ 30.40 per share. | 13 Mar 2019 | 3,300 | 20,821 (0%) | 0% | 30.4 | 100,331 | Common Stock |
| Dominic J. Andreano | SVP, General Counsel and Secy | Sale of securities on an exchange or to another person at price $ 30.16 per share. | 07 Mar 2019 | 4,608 | 64,461 (0%) | 0% | 30.2 | 138,984 | Common Stock |
| David A. Clark | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 32.90 per share. | 01 Mar 2019 | 6,452 | 136,964 (0%) | 0% | 32.9 | 212,262 | Common Stock |
| Joseph M. Calabro | President | Sale of securities on an exchange or to another person at price $ 32.91 per share. | 01 Mar 2019 | 12,130 | 429,408 (0%) | 0% | 32.9 | 399,197 | Common Stock |
| Roger J. Medel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.91 per share. | 01 Mar 2019 | 19,331 | 1,558,878 (1%) | 0% | 32.9 | 636,183 | Common Stock |
| Waldemar A. Carlo | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 17,584 | 0 | - | - | Stock Options (Right to Buy) | |
| Waldemar A. Carlo | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.94 per share. | 28 Feb 2019 | 10,095 | 27,085 (0%) | 0% | 32.9 | 332,529 | Common Stock |
| Waldemar A. Carlo | None | Grant, award, or other acquisition of securities at price $ 18.91 per share. | 28 Feb 2019 | 17,584 | 37,180 (0%) | 0% | 18.9 | 332,513 | Common Stock |
| Enrique J. Sosa | None | Grant, award, or other acquisition of securities at price $ 18.91 per share. | 27 Feb 2019 | 17,584 | 42,589 (0%) | 0% | 18.9 | 332,513 | Common Stock |
| Enrique J. Sosa | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2019 | 17,584 | 0 | - | - | Stock Options (Right to Buy) | |
| Enrique J. Sosa | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.40 per share. | 27 Feb 2019 | 9,956 | 32,633 (0%) | 0% | 33.4 | 332,530 | Common Stock |
| Dominic J. Andreano | SVP, General Counsel and Secy | Sale of securities on an exchange or to another person at price $ 36.22 per share. | 20 Feb 2019 | 1,289 | 69,069 (0%) | 0% | 36.2 | 46,690 | Common Stock |
| David A. Clark | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2019 | 56,571 | 143,416 (0%) | 0% | 0 | Common Stock | |
| Enrique J. Sosa | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2019 | 3,699 | 25,005 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Calabro | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2019 | 108,791 | 441,538 (0%) | 0% | 0 | `Common Stock | |
| Pascal J. Goldschmidt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2019 | 3,699 | 24,121 (0%) | 0% | 0 | Common Stock | |
| Paul G. Gabos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2019 | 3,699 | 19,596 (0%) | 0% | 0 | Common Stock | |
| Stephen D. Farber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2019 | 69,626 | 169,626 (0%) | 0% | 0 | Common Stock | |
| Waldemar A. Carlo | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2019 | 3,699 | 19,596 (0%) | 0% | 0 | Common Stock | |
| Cesar L. Alvarez | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2019 | 3,699 | 43,686 (0%) | 0% | 0 | Common Stock | |
| Michael B. Fernandez | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2019 | 3,699 | 100,288 (0%) | 0% | 0 | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2019 | 178,417 | 1,578,209 (1%) | 0% | 0 | Common Stock | |
| Manuel Kadre | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2019 | 3,699 | 119,596 (0%) | 0% | 0 | Common Stock | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2019 | 30,462 | 70,358 (0%) | 0% | 0 | Common Stock | |
| Karey D. Barker | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2019 | 3,699 | 13,061 (0%) | 0% | 0 | Common Stock | |
| John C. Pepia | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2019 | 7,253 | 35,877 (0%) | 0% | 0 | Common Stock | |
| John C. Pepia | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 36.60 per share. | 22 Jan 2019 | 2,500 | 28,583 (0%) | 0% | 36.6 | 91,500 | Common Stock |
| David A. Clark | Pres. Mednax Natl Med Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2018 | 54,000 | 86,845 (0%) | 0% | 0 | Common Stock | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2018 | 15,000 | 39,896 (0%) | 0% | 0 | Common Stock | |
| Vivian Lopez-Blanco | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 46.46 per share. | 12 Jun 2018 | 13,942 | 100,590 (0%) | 0% | 46.5 | 647,775 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 46.56 per share. | 12 Jun 2018 | 6,516 | 31,083 (0%) | 0% | 46.6 | 303,374 | Common Stock |
| Dominic J. Andreano | SVP, General Counsel and Secy | Sale of securities on an exchange or to another person at price $ 46.95 per share. | 11 Jun 2018 | 18,000 | 24,896 (0%) | 0% | 46.9 | 845,059 | Common Stock |
| David A. Clark | Pres. Mednax Natl Med Group | Sale of securities on an exchange or to another person at price $ 45.15 per share. | 01 Jun 2018 | 11,607 | 32,845 (0%) | 0% | 45.2 | 524,096 | Common Stock |
| Joseph M. Calabro | President and COO | Sale of securities on an exchange or to another person at price $ 45.20 per share. | 01 Jun 2018 | 22,186 | 332,747 (0%) | 0% | 45.2 | 1,002,738 | Common Stock |
| Roger J. Medel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.85 per share. | 01 Jun 2018 | 36,386 | 1,399,792 (1%) | 0% | 45.8 | 1,668,298 | Common Stock |
| Vivian Lopez-Blanco | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.85 per share. | 01 Jun 2018 | 7,395 | 114,532 (0%) | 0% | 45.9 | 339,061 | Common Stock |
| Dominic J. Andreano | SVP, General Counsel and Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.91 per share. | 24 May 2018 | 4,143 | 42,896 (0%) | 0% | 46.9 | 194,348 | Common Stock |
| Dominic J. Andreano | SVP, General Counsel and Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2018 | 6,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.72 per share. | 24 May 2018 | 6,000 | 47,039 (0%) | 0% | 27.7 | 166,290 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2018 | 3,000 | 0 | - | - | Stock Options (Right to Buy) | |
| John C. Pepia | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.72 per share. | 22 May 2018 | 3,000 | 39,716 (0%) | 0% | 27.7 | 83,145 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 46.43 per share. | 22 May 2018 | 3,000 | 36,716 (0%) | 0% | 46.4 | 139,290 | Common Stock |
| Vivian Lopez-Blanco | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2018 | 40,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Vivian Lopez-Blanco | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.60 per share. | 21 May 2018 | 26,058 | 121,927 (0%) | 0% | 46.6 | 1,214,303 | Common Stock |
| Vivian Lopez-Blanco | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.14 per share. | 21 May 2018 | 40,000 | 147,985 (0%) | 0% | 25.1 | 1,005,600 | Common Stock |
| Cesar L. Alvarez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2018 | 10,668 | 0 | - | - | Stock Options (Right to Buy) | |
| Cesar L. Alvarez | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.95 per share. | 04 May 2018 | 6,578 | 39,987 (0%) | 0% | 44.9 | 295,681 | Common Stock |
| Cesar L. Alvarez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.72 per share. | 04 May 2018 | 10,668 | 46,565 (0%) | 0% | 27.7 | 295,664 | Common Stock |
| Enrique J. Sosa | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.72 per share. | 19 Mar 2018 | 10,668 | 26,565 (0%) | 0% | 27.7 | 295,664 | Common Stock |
| Enrique J. Sosa | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2018 | 10,668 | 0 | - | - | Stock Option (Right to Buy) | |
| Enrique J. Sosa | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.23 per share. | 19 Mar 2018 | 5,259 | 21,306 (0%) | 0% | 56.2 | 295,714 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.72 per share. | 13 Mar 2018 | 3,000 | 39,716 (0%) | 0% | 27.7 | 83,145 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2018 | 3,000 | 3,000 | - | - | Stock Options (Right to Buy) | |
| John C. Pepia | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 58.35 per share. | 13 Mar 2018 | 3,000 | 36,716 (0%) | 0% | 58.4 | 175,063 | Common Stock |
| David A. Clark | Pres. Mednax Natl Med Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 19,352 | 44,452 (0%) | 0% | 0 | Common Stock | |
| Donna E. Shalala | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 2,350 | 16,947 (0%) | 0% | 0 | Common Stock | |
| Enrique J. Sosa | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 2,350 | 15,897 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Calabro | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 92,149 | 354,933 (0%) | 0% | 0 | Common Stock | |
| Pascal J. Goldschmidt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 2,350 | 20,422 (0%) | 0% | 0 | Common Stock | |
| Paul G. Gabos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 2,350 | 15,897 (0%) | 0% | 0 | Common Stock | |
| Waldemar A. Carlo | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 2,350 | 15,897 (0%) | 0% | 0 | Common Stock | |
| Cesar L. Alvarez | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 2,350 | 35,897 (0%) | 0% | 0 | Common Stock | |
| Michael B. Fernandez | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 2,350 | 96,589 (0%) | 0% | 0 | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 147,439 | 1,436,178 (1%) | 0% | 0 | Common Stock | |
| Manuel Kadre | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 2,350 | 115,897 (0%) | 0% | 0 | Common Stock | |
| Vivian Lopez-Blanco | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 36,860 | 107,985 (0%) | 0% | 0 | Common Stock | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 13,823 | 41,039 (0%) | 0% | 0 | Common Stock | |
| Karey D. Barker | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 2,350 | 9,362 (0%) | 0% | 0 | Common Stock | |
| John C. Pepia | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2018 | 4,147 | 36,716 (0%) | 0% | 0 | Common Stock | |
| John C. Pepia | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 51.58 per share. | 12 Dec 2017 | 3,000 | 32,569 (0%) | 0% | 51.6 | 154,740 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2017 | 3,000 | 6,000 | - | - | Stock Options (Right to Buy) | |
| John C. Pepia | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.72 per share. | 12 Dec 2017 | 3,000 | 35,569 (0%) | 0% | 27.7 | 83,145 | Common Stock |
| David A. Clark | Pres. Mednax Natl Med Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2017 | 14,741 | 14,741 | - | - | Restricted Shares Units | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2017 | 9,828 | 9,828 | - | - | Restricted Shares Units | |
| John C. Pepia | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2017 | 7,862 | 7,862 | - | - | Restricted Shares Units | |
| Cesar L. Alvarez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.32 per share. | 01 Nov 2017 | 10,668 | 44,215 (0%) | 0% | 32.3 | 344,843 | Common Stock |
| Cesar L. Alvarez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2017 | 10,668 | 0 | - | - | Stock Options (Right to Buy) | |
| Cesar L. Alvarez | None | Sale of securities on an exchange or to another person at price $ 42.59 per share. | 01 Nov 2017 | 10,668 | 33,547 (0%) | 0% | 42.6 | 454,375 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2017 | 3,000 | 9,000 | - | - | Stock Options (Right to Buy) | |
| John C. Pepia | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 42.85 per share. | 12 Sep 2017 | 3,000 | 32,569 (0%) | 0% | 42.9 | 128,550 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.72 per share. | 12 Sep 2017 | 3,000 | 35,569 (0%) | 0% | 27.7 | 83,145 | Common Stock |
| David A. Clark | Pres. Mednax Natl Med Group | Sale of securities on an exchange or to another person at price $ 54.99 per share. | 01 Jun 2017 | 10,202 | 25,100 (0%) | 0% | 55.0 | 561,041 | Common Stock |
| David A. Clark | Pres. Mednax Natl Med Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 15,277 | 35,302 (0%) | 0% | 0 | Common Stock | |
| Donna E. Shalala | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 2,292 | 14,597 (0%) | 0% | 0 | Common Stock | |
| Enrique J. Sosa | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 2,292 | 13,547 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Calabro | President and COO | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 01 Jun 2017 | 23,327 | 262,784 (0%) | 0% | 55.0 | 1,282,934 | Common Stock |
| Joseph M. Calabro | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 67,398 | 296,379 (0%) | 0% | 0 | Common Stock | |
| Pascal J. Goldschmidt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 2,292 | 20,041 (0%) | 0% | 0 | Common Stock | |
| Paul G. Gabos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 2,292 | 13,547 (0%) | 0% | 0 | Common Stock | |
| Waldemar A. Carlo | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 2,292 | 13,547 (0%) | 0% | 0 | Common Stock | |
| Cesar L. Alvarez | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 2,292 | 33,547 (0%) | 0% | 0 | Common Stock | |
| Michael B. Fernandez | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 2,292 | 94,239 (0%) | 0% | 0 | Common Stock | |
| Manuel Kadre | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 2,292 | 113,547 (0%) | 0% | 0 | Common Stock | |
| Vivian Lopez-Blanco | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 23,365 | 71,125 (0%) | 0% | 0 | Common Stock | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 8,987 | 27,216 (0%) | 0% | 0 | Common Stock | |
| Karey D. Barker | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 2,292 | 7,012 (0%) | 0% | 0 | Common Stock | |
| John C. Pepia | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 4,044 | 32,569 (0%) | 0% | 0 | Common Stock | |
| Manuel Kadre | None | Purchase of securities on an exchange or from another person at price $ 55.79 per share. | 05 May 2017 | 21,704 | 111,255 (0%) | 0% | 55.8 | 1,210,838 | Common Stock |
| Vivian Lopez-Blanco | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.82 per share. | 05 May 2017 | 7,778 | 51,319 (0%) | 0% | 55.8 | 434,183 | Common Stock |
| Dominic J. Andreano | SVP, General Counsel and Secy | Sale of securities on an exchange or to another person at price $ 70.84 per share. | 15 Mar 2017 | 6,517 | 18,229 (0%) | 0% | 70.8 | 461,645 | Common Stock |
| Enrique J. Sosa | None | Sale of securities on an exchange or to another person at price $ 69.65 per share. | 23 Feb 2017 | 10,668 | 11,255 (0%) | 0% | 69.7 | 743,060 | Common Stock |
| Enrique J. Sosa | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.32 per share. | 23 Feb 2017 | 10,668 | 21,923 (0%) | 0% | 32.3 | 344,843 | Common Stock |
| Enrique J. Sosa | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2017 | 10,668 | 0 | - | - | Stock Options (Right to Buy) | |
| Vivian Lopez-Blanco | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 70.01 per share. | 17 Feb 2017 | 15,164 | 59,097 (0%) | 0% | 70.0 | 1,061,606 | Common Stock |
| Paul G. Gabos | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2017 | 10,668 | 0 | - | - | Stock Options (Right to Buy) | |
| Paul G. Gabos | None | Sale of securities on an exchange or to another person at price $ 69.63 per share. | 16 Feb 2017 | 21,336 | 11,255 (0%) | 0% | 69.6 | 1,485,664 | Common Stock |
| Paul G. Gabos | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.72 per share. | 16 Feb 2017 | 10,668 | 32,591 (0%) | 0% | 27.7 | 295,664 | Common Stock |
| Paul G. Gabos | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.32 per share. | 16 Feb 2017 | 10,668 | 21,923 (0%) | 0% | 32.3 | 344,843 | Common Stock |
| Paul G. Gabos | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2017 | 10,668 | 0 | - | - | Stock Options (Right to Buy) | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2017 | 6,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.54 per share. | 16 Feb 2017 | 6,000 | 30,746 (0%) | 0% | 28.5 | 171,270 | Common Stock |
| Dominic J. Andreano | SVP, General Counsel and Secy | Sale of securities on an exchange or to another person at price $ 69.59 per share. | 16 Feb 2017 | 6,000 | 24,746 (0%) | 0% | 69.6 | 417,531 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2017 | 2,500 | 0 | - | - | Stock Options (Right to Buy) | |
| John C. Pepia | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 69.58 per share. | 16 Feb 2017 | 1,500 | 28,525 (0%) | 0% | 69.6 | 104,372 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 69.58 per share. | 16 Feb 2017 | 1,000 | 30,025 (0%) | 0% | 69.6 | 69,581 | Common Stock |
| John C. Pepia | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.55 per share. | 16 Feb 2017 | 2,500 | 31,025 (0%) | 0% | 28.5 | 71,363 | Common Stock |
| Roger J. Medel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 13 Feb 2017 | 38,257 | 1,288,739 (1%) | 0% | 0 | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2017 | 110,532 | 1,343,836 (1%) | 0% | 0 | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Feb 2017 | 16,020 | 1,233,304 (1%) | 0% | 0 | Common Stock | |
| Pascal J. Goldschmidt | None | Other type of transaction at price $ 67.82 per share. | 10 Feb 2017 | 25,294 | 17,749 (0%) | 0% | 67.8 | 1,715,318 | Common Stock |
| Waldemar A. Carlo | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2017 | 5,334 | 0 | - | - | Stock Options (Right to Buy) | |
| Waldemar A. Carlo | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.33 per share. | 09 Feb 2017 | 5,334 | 16,589 (0%) | 0% | 32.3 | 172,422 | Common Stock |
| Waldemar A. Carlo | None | Sale of securities on an exchange or to another person at price $ 67.90 per share. | 09 Feb 2017 | 5,334 | 11,255 (0%) | 0% | 67.9 | 362,186 | Common Stock |
| Vivian Lopez-Blanco | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 70.95 per share. | 17 Jan 2017 | 10,000 | 74,261 (0%) | 0% | 71.0 | 709,500 | Common Stock |
| Pascal J. Goldschmidt | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 Dec 2016 | 2,100 | 13,355 | - | - | Common Stock | |
| Manuel Kadre | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2016 | 26,668 | 0 | - | - | Stock Options (Right to Buy) | |
| Manuel Kadre | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2016 | 5,174 | 0 | - | - | Stock Options (Right to Buy) | |
| Manuel Kadre | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2016 | 10,668 | 0 | - | - | Stock Options (Right to Buy) | |
| Manuel Kadre | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2016 | 17,584 | 0 | - | - | Stock Options (Right to Buy) | |
| Manuel Kadre | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2016 | 9,922 | 0 | - | - | Stock Options (Right to Buy) | |
| Manuel Kadre | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2016 | 8,280 | 0 | - | - | Stock Options (Right to Buy) | |
| Manuel Kadre | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2016 | 26,668 | 37,923 | - | - | Common Stock | |
| Manuel Kadre | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2016 | 5,174 | 43,097 | - | - | Common Stock | |
| Manuel Kadre | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2016 | 10,668 | 53,765 | - | - | Common Stock | |
| Manuel Kadre | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2016 | 17,584 | 71,349 | - | - | Common Stock | |
| Manuel Kadre | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2016 | 9,922 | 81,271 | - | - | Common Stock | |
| Manuel Kadre | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2016 | 8,280 | 89,551 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2016 | 1,500 | 818 | - | - | Stock Options (Right to Buy) | |
| Pascal J. Goldschmidt | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2016 | 1,500 | 12,755 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Sep 2016 | 475 | 12,280 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Sep 2016 | 566 | 11,714 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Sep 2016 | 303 | 11,411 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Sep 2016 | 156 | 11,255 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Jun 2016 | 1,969 | 18,072 | - | - | Common Stock | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Jun 2016 | 3,922 | 24,746 | - | - | Common Stock | |
| Waldemar A. Carlo | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2016 | 5,334 | 5,334 | - | - | Stock Options (Right to Buy) | |
| Waldemar A. Carlo | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2016 | 5,334 | 16,589 | - | - | Common Stock | |
| Waldemar A. Carlo | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 08 Jun 2016 | 5,334 | 11,255 | - | - | Common Stock | |
| Karl B. Wagner | President, Eastern Division | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Jun 2016 | 27,482 | 105,932 | - | - | Common Stock | |
| Cesar L. Alvarez | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 1,876 | 31,255 | - | - | Common Stock | |
| Enrique J. Sosa | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 1,876 | 11,255 | - | - | Common Stock | |
| Joseph M. Calabro | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 55,156 | 253,882 | - | - | Common Stock | |
| Joseph M. Calabro | President and COO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Jun 2016 | 28,347 | 228,981 | - | - | Common Stock | |
| Karl B. Wagner | President, Eastern Division | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 23,901 | 133,414 | - | - | Common Stock | |
| Michael B. Fernandez | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 1,876 | 91,947 | - | - | Common Stock | |
| Paul G. Gabos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 1,876 | 11,255 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 90,455 | 1,290,163 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jun 2016 | 46,490 | 1,249,324 | - | - | Common Stock | |
| Waldemar A. Carlo | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 1,876 | 11,255 | - | - | Common Stock | |
| Donna E. Shalala | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 1,876 | 12,305 | - | - | Common Stock | |
| David A. Clark | President, Western Division | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 9,928 | 31,495 | - | - | Common Stock | |
| David A. Clark | President, Western Division | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Jun 2016 | 11,470 | 20,025 | - | - | Common Stock | |
| Michael Stanley | President, Clinical Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 12,135 | 49,266 | - | - | Common Stock | |
| Michael Stanley | President, Clinical Services | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Jun 2016 | 14,778 | 35,247 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 1,876 | 11,255 | - | - | Common Stock | |
| Manuel Kadre | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 1,876 | 11,255 | - | - | Common Stock | |
| Vivian Lopez-Blanco | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 19,121 | 84,261 | - | - | Common Stock | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 7,355 | 28,668 | - | - | Common Stock | |
| Karey D. Barker | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2016 | 1,876 | 4,720 | - | - | Common Stock | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 May 2016 | 3,000 | 21,313 | - | - | Common Stock | |
| Vivian Lopez-Blanco | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 May 2016 | 9,350 | 64,083 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2016 | 3,100 | 2,318 | - | - | Stock Options (Right to Buy) | |
| Pascal J. Goldschmidt | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2016 | 3,100 | 12,479 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Mar 2016 | 3,100 | 9,379 | - | - | Common Stock | |
| Paul G. Gabos | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2016 | 10,668 | 0 | - | - | Stock Options (Right to Buy) | |
| Paul G. Gabos | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2016 | 10,668 | 20,047 | - | - | Common Stock | |
| Paul G. Gabos | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Feb 2016 | 10,668 | 9,379 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2015 | 5,250 | 5,418 | - | - | Stock Options (Right to Buy) | |
| Pascal J. Goldschmidt | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2015 | 5,250 | 14,629 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Dec 2015 | 5,250 | 9,379 | - | - | Common Stock | |
| Cesar L. Alvarez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2015 | 10,668 | 0 | - | - | Stock Options (Right to Buy) | |
| Cesar L. Alvarez | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 08 Sep 2015 | 10,668 | 29,379 | - | - | Common Stock | |
| Cesar L. Alvarez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2015 | 10,668 | 40,047 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Aug 2015 | 100,000 | 1,199,708 | - | - | Common Stock | |
| Michael B. Fernandez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 11,722 | 0 | - | - | Stock Options (Right to Buy) | |
| Michael B. Fernandez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 10,668 | 49,479 | - | - | Common Stock | |
| Michael B. Fernandez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 8,280 | 90,071 | - | - | Common Stock | |
| Michael B. Fernandez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 7,112 | 0 | - | - | Stock Options (Right to Buy) | |
| Michael B. Fernandez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 9,922 | 0 | - | - | Stock Options (Right to Buy) | |
| Michael B. Fernandez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 10,668 | 60,147 | - | - | Common Stock | |
| Michael B. Fernandez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 10,668 | 0 | - | - | Stock Options (Right to Buy) | |
| Michael B. Fernandez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 8,280 | 0 | - | - | Stock Options (Right to Buy) | |
| Michael B. Fernandez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 11,722 | 71,869 | - | - | Common Stock | |
| Michael B. Fernandez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 10,668 | 0 | - | - | Stock Options (Right to Buy) | |
| Michael B. Fernandez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 7,112 | 38,811 | - | - | Common Stock | |
| Michael B. Fernandez | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 9,922 | 81,791 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 31 Jul 2015 | 1,500 | 9,379 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2015 | 1,500 | 10,879 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2015 | 1,500 | 0 | - | - | Stock Options (Right to Buy) | |
| Vivian Lopez-Blanco | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 31 Jul 2015 | 10,000 | 73,433 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2015 | 43,580 | 0 | - | - | Restricted Shares Units | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2015 | 43,580 | 1,317,990 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 28 Jul 2015 | 18,282 | 1,299,708 | - | - | Common Stock | |
| Karl B. Wagner | Pres, American Anesthesiology | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 08 Jun 2015 | 37,820 | 108,020 | - | - | Common Stock | |
| Cesar L. Alvarez | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 1,816 | 29,379 | - | - | Common Stock | |
| Enrique J. Sosa | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 1,816 | 9,379 | - | - | Common Stock | |
| Joseph M. Calabro | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 53,412 | 306,797 | - | - | Common Stock | |
| Joseph M. Calabro | President and COO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Jun 2015 | 70,153 | 198,726 | - | - | Common Stock | |
| Joseph M. Calabro | President and COO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Jun 2015 | 37,918 | 268,879 | - | - | Common Stock | |
| Michael B. Fernandez | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 1,816 | 31,699 | - | - | Common Stock | |
| Paul G. Gabos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 1,816 | 9,379 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 87,595 | 1,274,410 | - | - | Common Stock | |
| Waldemar A. Carlo | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 1,816 | 9,379 | - | - | Common Stock | |
| Donna E. Shalala | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 1,816 | 10,429 | - | - | Common Stock | |
| David A. Clark | COO, Pediatrix Medical Group | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Jun 2015 | 14,654 | 21,567 | - | - | Common Stock | |
| David A. Clark | COO, Pediatrix Medical Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 9,615 | 36,221 | - | - | Common Stock | |
| Michael Stanley | Pres., Pediatrix Medical Group | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Jun 2015 | 18,522 | 37,131 | - | - | Common Stock | |
| Michael Stanley | Pres., Pediatrix Medical Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 11,751 | 55,653 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 1,816 | 9,379 | - | - | Common Stock | |
| Manuel Kadre | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 1,816 | 9,379 | - | - | Common Stock | |
| Vivian Lopez-Blanco | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 16,380 | 83,433 | - | - | Common Stock | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2015 | 7,122 | 24,313 | - | - | Common Stock | |
| Karl B. Wagner | Pres, American Anesthesiology | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Mar 2015 | 7,500 | 122,695 | - | - | Common Stock | |
| Karl B. Wagner | Pres, American Anesthesiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2015 | 23,145 | 145,840 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2015 | 8,500 | 16,063 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Mar 2015 | 8,500 | 7,563 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2015 | 8,500 | 1,500 | - | - | Stock Options (Right to Buy) | |
| Roger J. Medel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Feb 2015 | 100,000 | 1,186,815 | - | - | Common Stock | |
| Waldemar A. Carlo | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2015 | 10,668 | 0 | - | - | Stock Options (Right to Buy) | |
| Waldemar A. Carlo | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 20 Feb 2015 | 10,668 | 7,563 | - | - | Common Stock | |
| Waldemar A. Carlo | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2015 | 10,668 | 18,231 | - | - | Common Stock | |
| Vivian Lopez-Blanco | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Feb 2015 | 8,250 | 67,053 | - | - | Common Stock | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Feb 2015 | 3,200 | 17,191 | - | - | Common Stock | |
| Paul G. Gabos | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Feb 2015 | 17,584 | 7,563 | - | - | Common Stock | |
| Paul G. Gabos | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2015 | 17,584 | 0 | - | - | Stock Options (Right to Buy) | |
| Paul G. Gabos | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2015 | 17,584 | 25,147 | - | - | Common Stock | |
| William C. Hawk | COO American Anesthesiology | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Jan 2015 | 3,598 | 11,549 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Nov 2014 | 51,290 | 1,286,815 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2014 | 51,290 | 0 | - | - | Stock Options (Right to Buy) | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2014 | 51,290 | 1,338,105 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Nov 2014 | 21,428 | 1,286,815 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Nov 2014 | 42,012 | 1,286,815 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2014 | 21,428 | 1,308,243 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2014 | 42,012 | 1,328,827 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2014 | 21,428 | 51,290 | - | - | Stock Options (Right to Buy) | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2014 | 42,012 | 72,718 | - | - | Stock Options (Right to Buy) | |
| Roger J. Medel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Nov 2014 | 125,248 | 1,286,815 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2014 | 3,585 | 1,290,400 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Nov 2014 | 3,585 | 1,286,815 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2014 | 3,585 | 114,730 | - | - | Stock Options (Right to Buy) | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2014 | 125,248 | 118,315 | - | - | Stock Options (Right to Buy) | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2014 | 125,248 | 1,412,063 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Nov 2014 | 143,912 | 1,286,815 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2014 | 37,475 | 0 | - | - | Stock Options(Right to Buy) | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2014 | 100,000 | 1,424,290 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2014 | 37,475 | 1,324,290 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2014 | 6,437 | 1,430,727 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2014 | 15,052 | 1,301,867 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Nov 2014 | 10,881 | 1,286,815 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Nov 2014 | 15,052 | 1,286,815 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2014 | 100,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2014 | 10,881 | 52,527 | - | - | Stock Options (Right to Buy) | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2014 | 15,052 | 37,475 | - | - | Stock Options (Right to Buy) | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2014 | 6,437 | 243,563 | - | - | Stock Options (Right to Buy) | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2014 | 10,881 | 1,297,696 | - | - | Common Stock | |
| Karl B. Wagner | Pres, American Anesthesiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2014 | 40,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Karl B. Wagner | Pres, American Anesthesiology | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Oct 2014 | 40,000 | 130,195 | - | - | Common Stock | |
| Karl B. Wagner | Pres, American Anesthesiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2014 | 40,000 | 170,195 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2014 | 36,509 | 88,491 | - | - | Stock Options (Right to Buy) | |
| Roger J. Medel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Oct 2014 | 36,509 | 1,286,815 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2014 | 25,083 | 63,408 | - | - | Stock Options (Right to Buy) | |
| Roger J. Medel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Oct 2014 | 25,083 | 1,286,815 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2014 | 25,083 | 1,311,898 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2014 | 36,509 | 1,323,324 | - | - | Common Stock | |
| Vivian Lopez-Blanco | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Oct 2014 | 8,800 | 75,303 | - | - | Common Stock | |
| Karl B. Wagner | Pres, American Anesthesiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2014 | 60,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Karl B. Wagner | Pres, American Anesthesiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2014 | 20,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Karl B. Wagner | Pres, American Anesthesiology | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Jul 2014 | 80,000 | 130,195 | - | - | Common Stock | |
| Karl B. Wagner | Pres, American Anesthesiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2014 | 20,000 | 150,195 | - | - | Common Stock | |
| Karl B. Wagner | Pres, American Anesthesiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2014 | 60,000 | 210,195 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2014 | 43,580 | 43,580 | - | - | Restricted Shares Units | |
| Roger J. Medel | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Jul 2014 | 19,265 | 1,261,517 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2014 | 43,580 | 1,305,097 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Jul 2014 | 18,282 | 1,286,815 | - | - | Common Stock | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Jun 2014 | 2,252 | 20,391 | - | - | Common Stock | |
| Karl B. Wagner | Pres, American Anesthesiology | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Jun 2014 | 44,596 | 130,195 | - | - | Common Stock | |
| William C. Hawk | COO American Anesthesiology | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Jun 2014 | 6,911 | 15,021 | - | - | Common Stock | |
| Cesar L. Alvarez | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 2,213 | 27,563 | - | - | Common Stock | |
| Enrique J. Sosa | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 2,213 | 7,563 | - | - | Common Stock | |
| Joseph M. Calabro | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 65,071 | 291,613 | - | - | Common Stock | |
| Joseph M. Calabro | President and COO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Jun 2014 | 38,228 | 253,385 | - | - | Common Stock | |
| Karl B. Wagner | Pres, American Anesthesiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 24,293 | 174,791 | - | - | Common Stock | |
| Michael B. Fernandez | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 2,213 | 29,883 | - | - | Common Stock | |
| Paul G. Gabos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 2,213 | 7,563 | - | - | Common Stock | |
| Roger J. Medel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 106,716 | 1,280,782 | - | - | Common Stock | |
| Roger K. Freeman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 2,213 | 7,013 | - | - | Common Stock | |
| Waldemar A. Carlo | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 2,213 | 7,563 | - | - | Common Stock | |
| Donna E. Shalala | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 2,213 | 8,613 | - | - | Common Stock | |
| David A. Clark | COO, Pediatrix Medical Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 11,062 | 42,836 | - | - | Common Stock | |
| David A. Clark | COO, Pediatrix Medical Group | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Jun 2014 | 16,230 | 26,606 | - | - | Common Stock | |
| Michael Stanley | Pres., Pediatrix Medical Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 14,316 | 61,908 | - | - | Common Stock | |
| Michael Stanley | Pres., Pediatrix Medical Group | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Jun 2014 | 18,006 | 43,902 | - | - | Common Stock | |
| Pascal J. Goldschmidt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 2,213 | 7,563 | - | - | Common Stock | |
| Manuel Kadre | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 2,213 | 7,563 | - | - | Common Stock | |
| William C. Hawk | COO American Anesthesiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 4,772 | 21,932 | - | - | Common Stock | |
| Vivian Lopez-Blanco | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 19,955 | 84,103 | - | - | Common Stock | |
| Dominic J. Andreano | SVP, General Counsel and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2014 | 6,508 | 22,643 | - | - | Common Stock | |
| Karl B. Wagner | Pres, American Anesthesiology | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 May 2014 | 36,250 | 150,498 | - | - | Common Stock | |
| Karl B. Wagner | Pres, American Anesthesiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2014 | 36,250 | 20,000 | - | - | Stock Options (Right to Buy) | |
| Karl B. Wagner | Pres, American Anesthesiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2014 | 36,250 | 186,748 | - | - | Common Stock | |
| Karl B. Wagner | Pres, American Anesthesiology | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 May 2014 | 43,274 | 150,498 | - | - | Common Stock |